ESTRO 35 2016 ______________________________________________________________________________________________________ the MRL, as well as measurable paramagnetic changes observed using the 1.5 T MRI component of the MRL during and after irradiation. To our knowledge, this is the first time the dose accumulation inside a 3D dosimeter has been visualized in real-time during irradiation using the MRL. The results of this study warrant further investigations into the use of 3D dosimeters for the verification of patient specific radiation therapy treatment plans for the MRL.
Purpose or Objective:
In radiotherapy, the development of bidimensional detectors with the suitable dosimetric features for pretreatment quality assurance of the new advanced treatment techniques is of interest. Diamond is a valid candidate as real-time dosimeter since, contrary to silicon, it is an almost tissue equivalent material showing in principle no energy dependence. Furthermore, it is possible to product large-area polycrystalline diamond wafers with suitable electronic properties. In this study we describe the performance of DIAPIX, a large area dosimeter used for pretreatment verification of intensity modulated treatment plans.
Material and Methods:
The dosimeter is made of two detector-grade adjacent 2.5x2.5cm2 polycrystalline Chemical Vapour Deposited (pCVD) diamond samples, each equipped with a 12x12 matrix of 144 contacts with a pitch of 2mm, connected to a custom-made electronic read-out system. Tests of the pCVD diamond dosimeter have been performed by means of an Elekta Synergy LINAC, with conventional photon beams, with clinical IMRT fields, from prostate and breast cancer, and with a VMAT lung treatments. The dosimeter was placed at the isocenter and sandwiched inside a phantom of water equivalent material. First set of measurements under a conventional radiotherapy beam aimed to verify the correct behavior of the whole matrix under a flat field and to obtain a flatness correction factor for each pixel were performed. Afterwards dosimetric maps were acquired. Since the area of the prototype under study is smaller respect to a typical IMRT field, the dosimeter was firstly positioned at the isocenter and then shifted in the Latero-Lateral direction. QA plans were computed on the phantom using the Treatment Planning System (TPS) Monaco v3.2., which uses a MonteCarlo algorithm to compute the dose distribution, with a dose grid of 2 mm, and Pinnacle v9.2 which uses a collapsed cone convolution respectively for the VMAT and IMRT plan.
Results:
A comparison between the measured maps and the ones predicted by the TPS was performed. As an example, in fig 1 is reported the map collected of lung VMAT plan and the comparison between the measured profiles of some pixels and the ones calculated by Monaco TPS. Dose differences with TPS are in general within 5%, apart in the penumbra region where the dose gradient is high and where the distance-to-agreement is within 3mm.
Conclusion:
Dose profiles compare favorably with TPS both for IMRT and VMAT. These results demonstrate that the pCVD diamond device is a suitable detector for dosimetric pretreatment verification analysis in modulated radiation therapy and for conformal beams. This allows for the development of a large area monolithic device with high spatial resolution. In a next future, three samples will be put together in order to realize a matrix with 432 pixels with a total area of 7.5x2.5 cm2. This work has been supported by the experiments INFN CSN5 DIAPIX and IRPT/MIUR.
Poster: Physics track: Dose measurement and dose calculation

PO-0802 Monte-Carlo based validation of accelerator beam base data measurements M. Alber
Purpose or Objective: The quality of beam base data (BBD) is crucial for the accuracy of dose computation, because every measurement error translates into a systematic dose computation error. Despite elaborate guidelines and recommendations, the quality of BBD measurements cannot be verified directly. This constitutes a gap in the clinical QA chain. We present a Monte-Carlo (MC) based method to validate the self-consistency and overall quality of typical BBD measurements.
Material and Methods:
BBD are naturally not independent; therefore, self-consistency is a sensitive indicator. Ideally, a full MC simulation, starting with the primary electron beam, would allow benchmarking of individual measurements. This requires that the electron beam properties are known, which can in turn only be determined indirectly from measurements of the photon fields, resulting in a circular problem; not to mention that full linac simulations with a final uncertainty fit for this purpose still require a long time. Thus, we propose: for each accelerator type, a number of electron beam tunes are simulated with BEAMnrc and the phase spaces recorded. The phase spaces are then decomposed into 5 sources and each source is described by a parametric model. The model parameters are naturally highly correlated and yield a unique parameter fingerprint of the beam tune. Given that the photon dose distribution of each source is known, the model parameters of a BBD set can be derived by a fitting process. If a parameter fingerprint of a measurement does not follow ________________________________________________________________________________ the previously established correlation patterns, the measurement can be considered problematic, and the most probable parameter fingerprint can be determined by mixing the base fingerprints.
Results: Parameter fingerprints for the most frequent energies of Varian and Elekta linacs were generated and used to validate BBD. The method is very sensitive to problems with depth-dose curves (DDC), e.g. incorrect placement of the sensitive volume of the detector, spectral dependencies of the detector for large fields/large depths, partial-volume-, cable-and scatter-effects. Due to the virtually absent scatter in small fields, MC is the ideal method to augment and validate the self-consistency of small field dosimetry. The precision of error detection is in the range of 0.1 mm detector position shifts and 0.3% dose error, for DDC from 5x5 mm² to 400x400 mm². Output factor variations can be detected with a sensitivity of 0.2%, MLC positioning uncertainty with a sensitivity of 0.1 mm. Typical issues with detector types and accelerator models can be identified.
Conclusion:
Monte-Carlo derived phase space abstractions can be used to validate the self-consistency and overall quality of base data measurements and thereby fill a gap in the quality assurance chain. Base data can be validated with an accuracy of 0.3%, being one order of magnitude better than potential experimental errors. 
PO-0803 Validation of a pre-treatment delivery quality assurance method for the CyberKnife Synchrony System
Material and Methods:
An EasyCube Phantom (Sun Nuclear), consisting of RW3 slabs, was mounted on the ExacTrac (ET) Gating Phantom (Brainlab), which can move along the superior-inferior axis of the patient to simulate a moving target. Eight fiducial markers were implanted in the EasyCube for the treatment set-up and for the tracking. A Gafchromic EBT3 film (Ashland) was positioned between two slabs of the EasyCube, while a PinPoint ionization chamber (PTW) was placed in an appropriate insert. The EBT3 films were calibrated with a 6MV beam (Trilogy, Varian) from 0 to 15 Gy and analysed with the multichannel film dosimetry performed by the FilmQA Pro software (Ashland). Our evaluation was performed in two steps: 1) the films were irradiated with single fields perpendicular to the EasyCube for several collimators (3 fixed collimators: 15, 30, 60mm; 3 IRIS openings: 20, 30 and 40mm) and in different dynamic conditions (e.g. motion amplitude of the ET Phantom from 8 to 28 mm). The delivered and planned dose distributions were compared with the gamma (γ) analysis method. The local γ passing rates (GP) were evaluated using 3 acceptance criteria, varying the local dose difference (LDD), the distance-to-agreement (DTA) and the dose threshold (TH): 3%/3mm TH = 10%, 2%/2mm TH = 30% and 3%/1mm TH=50%.Dynamic cases were also delivered with purposefully simulated errors (RTS switched off or low coverage of the respiratory correlation model).
2) The DQA plans of 6 clinical patients were delivered in different dynamic conditions, for a total of 19 cases. The measured and planned dose distributions were evaluated with the same γ-index criteria of step 1 and the measured PinPoint doses were compared with the planned mean doses in the sensitive volume of the chamber.
The test was considered passed if the 3 γ analysis criteria yielded a GP>90% or at least 2 criteria yielded a GP>90% and the PinPoint dose difference (ΔD) was <5.0%.
Results:
The γ analysis of the collimators showed the need to use more γ-index criteria to detect the simulated errors. Only the stricter DTA criterion drastically failed the test, with GP<70%. All of the DQA plans passed the tests, both in static and dynamic conditions. The mean GP (±σ) were 95.5±5.2% (3%/3mm), 98.6±1.4% (2%/2mm) and 97.8±2.2% (3%/1mm).The mean ΔD was 2.9±1.8%. No significant differences were found between the static and the dynamic cases.
Conclusion:
The presented method confirms the ability of the RTS, if used properly, to treat a moving target with great precision. Our pre-treatment patient-specific DQA method was robust, combining PinPoint dose measurements and an evaluation of dose distributions with EBT3 films. However, we found the need of a detailed study of each case, especially when one acceptance criterion does not satisfy the tolerance level. [1] . In this work weuse this code for: -Recalculationof a clinically approved plan from the TPS, to evaluate the quality of our TPSsemi-analytical dose calculation algorithm at the level of the individualpatient -Recalculationof a treatment session using the Log File coming from the Therapy ControlSystem (TCS), to evaluate differences in 3D dose distribution in patientanatomy taking into account the characteristics of spots (energy, position, MUetc.) as actually delivered by the machine -Simulationof a 2D patient specific QA (2DQA). This is aretrospective study on 10 patients done to evaluate the possibility ofsubstituting our actual 2DQA measurement process with a completely automatic andreliable MC based workflow.
PO-0804
For each 2DQA TPS and MC dose distributionsrecalculated in water equivalent material, at different depths, were comparedwith measurements performed with an array of 1020 ionization chambers
